Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy

Canadian Journal of Ophthalmology

Volumn 48, Issue 2, 2013, Pages 88-92

  Hua, Wen ^a   Cao, Sijia ^b   Cui, Jing ^b   Maberley, David ^b   Matsubara, Joanne ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; DIABETIC RETINOPATHY; FEAR; FEMALE; HUMAN; LASER COAGULATION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT REFUSAL;

EID: 84880016799     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/j.jcjo.2012.09.012     Document Type: Article

References (40)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-74. (Pubitemid 15197017)
2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Ophthalmology. 1984;102:527-32. (Pubitemid 14127839)
3. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105:998-1003. (Pubitemid 28268322)
4. Preti RC, Motta AA, Maia Ode O Jr, et al. Relationship between diabetic retinopathy severity and the timespan between the endocrinopathy diagnosis and the first ophthalmic examination. Arq Bras Oftalmol. 2010;73:240-3.
5. Khandekar R. Mohammed AJ. Visual disabilities among diabetics in Oman. Saudi Med J. 2005;26:836-41. (Pubitemid 40903352)
6. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090-101.
7. Wang N, Xu X, Zou H, Zhu J, Wang W, Ho PC. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: A survey from Beixinjing District of Shanghai city in China. Ophthalmologica. 2008;222:32-6. (Pubitemid 350308334)
8. Xie XW, Xu L, Wang YX, Jonas JB. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol. 2008;246:1519-26.
9. Fong DS, Aiello L, Gardner TW, et al. Retinopathy in diabetes. Diabetes Care.. 2004;27:S84-7. (Pubitemid 38197476)
10. Screening guidelines for diabetic retinopathy. American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Ann Intern Med. 1992;116:683-85.
11. Peng J, Zou H, Wang W, et al. Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Serv Res. 2011;11:250.
12. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88(7):583-600.
13. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):766-85.
14. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL 3rd. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1992;99:1351-7.
15. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103:1796-806.
16. Diabetic Retinopathy Clinical Research Network; Browning DJ, Glassman AR, Aiello LP, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525-36.
17. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1986;93:938-50. (Pubitemid 16046104)
18. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110:1952-9. (Pubitemid 37163313)
19. Paz SH, Varma R, Klein R, Wu J, Azen SP. Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113:1372-7. (Pubitemid 44108195)
20. Will JC, German RR, Schuman E, Michael S, Kurth DM, Deeb L. Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study. Am J Public Health. 1994;84:1669-71. (Pubitemid 24323433)
21. Khandekar R, Al Lawati J, Barakat N. A retrieval system for patients with avoidable blindness due to diabetic retinopathy who do not present for ophthalmic assessment in Oman. Middle East Afr J Ophthalmol. 2011;18:93-7.
22. Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol. 1999;6:61-72. (Pubitemid 29313003)
23. Cuadros J, Bresnick G. EyePACS: an adaptable telemedicine system for diabetic retinopathy screening. J Diabetes Sci Technol. 2009;3:509-16.
24. Vine AK. The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy. Ophthalmology. 1985;92:1532-7. (Pubitemid 16203716)
25. Kaufman SC, Ferris FL 3rd, Seigel DG, Davis MD, DeMets DL. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report 3. Invest Ophthalmol Vis Sci. 1989;30:23-8. (Pubitemid 19039875)
26. Reddy VM, Zamora RL, Olk RJ. Quantitation of retinal ablation in proliferative diabetic retinopathy. Am J Ophthalmol. 1995;119:60-766.
27. Reno PL, Arfken CL, Heins JM, Fisher EB Jr. Factors that influence the decision to receive treatment for proliferative diabetic retinopathy. Diabetes Educ. 1997;23:653-5. (Pubitemid 127458265)
28. Zhang X, Norris SL, Saadine J, et al. Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med. 2007;33:318-35. (Pubitemid 47411672)
29. Walker EA, Schechter CB, Caban A, Basch CE. Telephone intervention to promote diabetic retinopathy screening among the urban poor. Am J Prev Med. 2008;34:185-91. (Pubitemid 351220951)
30. Halbert RJ, Leung KM, Nichol JM, Legorreta AP. Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial. Diabetes Care. 1999;22:752-5. (Pubitemid 29220774)
31. Wolbarsht ML, Landers MB 3rd. The rationale of photocoagulation therapy for proliferative diabetic retinopathy: a review and a model. Ophthalmic Surg. 1980;11:235-45. (Pubitemid 10088620)
32. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298:902-16. (Pubitemid 47311296)
33. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991;98:741-56.
34. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124:164-9. (Pubitemid 26011617)
35. Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care. 1994;17:909-17. (Pubitemid 24235519)
36. Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE. Costeffectiveness of strategies for detecting diabetic retinopathy. Med Care. 1991;29:20-39.
37. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin. 1987;27:254-64.
38. Fong DS, Girach A, Boney A. Visual side effects ofsuccessful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review. Retina. 2007;27:816-24. (Pubitemid 47479374)
39. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1995;113:1144-155.
40. Liu M, Zhang Q, Lu M, Kwon CS, Quan H. Rural and urban disparity in health services utilization in China. Med Care. 2007;45:767-74.